A strategy for the treatment of calcific uremic arteriolopathy (calciphylaxis) employing a combination of therapies

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Calcific uremic arteriolopathy (calciphylaxis) is one of the more devastating complications that can develop in patients with chronic renal failure. This disorder is associated with calcium-phosphorus deposition in the subcutaneous arterial vessels and presents as a progressive ischemic necrosis of the skin resulting in large subcutaneous ulcerations with eschar formation. Mortality rates are substantially greater in chronic renal failure patients with calciphylaxis, and the major cause of death is infection and sepsis. We have developed a treatment strategy that employs a combination of therapies, which is based on reducing the known risk factors for the development of calciphylaxis as well as utilization of a number of treatment modalities that have been proven successful in the treatment of this disorder.

Original languageEnglish (US)
Pages (from-to)463-470
Number of pages8
JournalClinical Nephrology
Volume59
Issue number6
StatePublished - Jun 1 2003

Fingerprint

Calciphylaxis
Chronic Kidney Failure
Therapeutics
Phosphorus
Cause of Death
Sepsis
Necrosis
Calcium
Skin
Mortality
Infection

Keywords

  • Calcific uremic arteriolopathy
  • Calciphylaxis
  • Therapy

ASJC Scopus subject areas

  • Nephrology

Cite this

@article{46c177e4befe47b8826ea201bcb5d7d0,
title = "A strategy for the treatment of calcific uremic arteriolopathy (calciphylaxis) employing a combination of therapies",
abstract = "Calcific uremic arteriolopathy (calciphylaxis) is one of the more devastating complications that can develop in patients with chronic renal failure. This disorder is associated with calcium-phosphorus deposition in the subcutaneous arterial vessels and presents as a progressive ischemic necrosis of the skin resulting in large subcutaneous ulcerations with eschar formation. Mortality rates are substantially greater in chronic renal failure patients with calciphylaxis, and the major cause of death is infection and sepsis. We have developed a treatment strategy that employs a combination of therapies, which is based on reducing the known risk factors for the development of calciphylaxis as well as utilization of a number of treatment modalities that have been proven successful in the treatment of this disorder.",
keywords = "Calcific uremic arteriolopathy, Calciphylaxis, Therapy",
author = "Don, {Burl R} and Chin, {Andrew I}",
year = "2003",
month = "6",
day = "1",
language = "English (US)",
volume = "59",
pages = "463--470",
journal = "Clinical Nephrology",
issn = "0301-0430",
publisher = "Dustri-Verlag Dr. Karl Feistle",
number = "6",

}

TY - JOUR

T1 - A strategy for the treatment of calcific uremic arteriolopathy (calciphylaxis) employing a combination of therapies

AU - Don, Burl R

AU - Chin, Andrew I

PY - 2003/6/1

Y1 - 2003/6/1

N2 - Calcific uremic arteriolopathy (calciphylaxis) is one of the more devastating complications that can develop in patients with chronic renal failure. This disorder is associated with calcium-phosphorus deposition in the subcutaneous arterial vessels and presents as a progressive ischemic necrosis of the skin resulting in large subcutaneous ulcerations with eschar formation. Mortality rates are substantially greater in chronic renal failure patients with calciphylaxis, and the major cause of death is infection and sepsis. We have developed a treatment strategy that employs a combination of therapies, which is based on reducing the known risk factors for the development of calciphylaxis as well as utilization of a number of treatment modalities that have been proven successful in the treatment of this disorder.

AB - Calcific uremic arteriolopathy (calciphylaxis) is one of the more devastating complications that can develop in patients with chronic renal failure. This disorder is associated with calcium-phosphorus deposition in the subcutaneous arterial vessels and presents as a progressive ischemic necrosis of the skin resulting in large subcutaneous ulcerations with eschar formation. Mortality rates are substantially greater in chronic renal failure patients with calciphylaxis, and the major cause of death is infection and sepsis. We have developed a treatment strategy that employs a combination of therapies, which is based on reducing the known risk factors for the development of calciphylaxis as well as utilization of a number of treatment modalities that have been proven successful in the treatment of this disorder.

KW - Calcific uremic arteriolopathy

KW - Calciphylaxis

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=0038039183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038039183&partnerID=8YFLogxK

M3 - Article

C2 - 12834180

AN - SCOPUS:0038039183

VL - 59

SP - 463

EP - 470

JO - Clinical Nephrology

JF - Clinical Nephrology

SN - 0301-0430

IS - 6

ER -